Grants and Contributions:
Title:
Creating Innovative and Novel Viscoelastometric Base IVD Reagent Technology for Universal Platform Application
Agreement Number:
866468
Agreement Value:
$10,000.00
Agreement Date:
May 16, 2016 - Aug 31, 2018
Description:
A new approach for monitoring blood clotting profiles that will significantly improve the prediction of catastrophic bleeding or thrombotic risk in ambulatory, surgical and emergency clinical settings._x000D_
_x000D_
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Windsor, Nova Scotia, CA B0N 2T0
Reference Number:
172-2018-2019-Q1-866468
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
896490125
Recipient Type:
For-profit organization
Additional Information:
The end date of this agreement has been modified by 105 days.
Amendment Date
May 18, 2018
Recipient's Operating Name:
BioMedica Diagnostics Inc
Recipient's Legal Name:
BioMedica Diagnostics Inc.
Federal Riding Name:
Kings--Hants
Federal Riding Number:
12007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: